1-18 of 18
Vijaya Raj Bhatt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Hematopoietic Cell Transplantation (HCT) Frailty Is Associated with Lower Cognitive Function and Health-Related Quality of Life (HRQOL) in Older Adults Undergoing HCT

Thuy T Koll, Megan Kerns, Tanya M. Wildes, Vijaya Raj Bhatt, Krishna Gundabolu, Lori Maness, Michael Haddadin, Marcia Free, Elizabeth R Lyden, Daniel L Murman, Alfred L Fisher
Journal: Blood
Blood (2024) 144 (Supplement 1): 3550.
https://doi.org/10.1182/blood-2024-210392
Published: 2024
Journal Articles

The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704

Mohamed Sorror, Wael Saber, Brent R. Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Asmita Mishra, Joseph Uberti, Parastoo B Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence E Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph E. Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew Artz
Journal: Blood
Blood (2024) 144 (Supplement 1): 685.
https://doi.org/10.1182/blood-2024-194414
Published: 2024
Journal Articles

Association between Malnutrition and Inpatient Mortality in Hematopoietic Stem Cell Transplant (HSCT) Population: A Nationwide Inpatient Sample (NIS) Database Analysis

Michael Haddadin, Adham Obedat, Farah Al-Bitar, Lori Maness, Krishna Gundabolu, Shyam Ajay Patel, Vijaya Raj Bhatt
Journal: Blood
Blood (2024) 144 (Supplement 1): 2125.
https://doi.org/10.1182/blood-2024-204507
Published: 2024
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede Begna, Sameem Abedin, MHD Monzr M. Al Malki, Vijaya Raj Bhatt, Nathalie Javidi-Sharifi, Prabhu Rajagopolan, Sandra Wiley, Richard G Ghalie, Matthew S. Davids
Journal: Blood
Blood (2024) 144 (Supplement 1): 2878.
https://doi.org/10.1182/blood-2024-198718
Published: 2024
Journal Articles

Averting a terminal transplant cascade

Clinical Trials & Observations
Krishna Gundabolu, Vijaya Raj Bhatt
Journal: Blood
Blood (2024) 143 (12): 1059–1060.
https://doi.org/10.1182/blood.2023023199
Published: 2024
Journal Articles

Determining treatment tolerance and fitness for intensive chemotherapy in older adults with AML: a call to action

Vijaya Raj Bhatt, Geoffrey L. Uy, Heidi D. Klepin
Journal: Blood
Blood (2024) 143 (6): 483–487.
https://doi.org/10.1182/blood.2023022611
Published: 2024
Includes: Supplemental data
Journal Articles

Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial

Vijaya Raj Bhatt, Christopher Wichman, Thuy T Koll, Alfred Fisher, Tanya M. Wildes, Michael Haddadin, Ann Berger, James Olen Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4265.
https://doi.org/10.1182/blood-2023-178112
Published: 2023
Journal Articles

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Andrew Artz, Brent R. Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy Schuler, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 109.
https://doi.org/10.1182/blood-2023-173855
Published: 2023
Journal Articles

A Phase I, Single-Arm, Open Label, Dose Escalation, Multicenter Study of Off-the-Shelf Natural Killer (NK) Cells (SAR445419) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Marina Y. Konopleva, Vijaya Raj Bhatt, Ioannis Mantzaris, Abhishek Maiti, Krishna Gundabolu, Kyle Jensen, Jolie Schafer, Gu Mi, Agata Drewniak, Heidi Krenz, Rao Saleem, Giovanni Abbadessa, Naval Daver
Journal: Blood
Blood (2023) 142 (Supplement 1): 5972.
https://doi.org/10.1182/blood-2023-174030
Published: 2023
Journal Articles

Preferences of Patients with Acute Myeloid Leukemia and Other Myeloid Malignancies on Cancer Treatment: Effect of Patient- and Treatment-Characteristics?

Prajwal Dhakal, Christopher Wichman, Bunny Pozehl, Kalika Mahato, Vijaya Raj Bhatt
Journal: Blood
Blood (2023) 142 (Supplement 1): 3731.
https://doi.org/10.1182/blood-2023-181346
Published: 2023
Journal Articles

North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need

Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R. Wilson, Marina Konopleva, Arthur E. Frankel, Vikas Gupta, Ruben Mesa, Matthew Ulrickson, Edward Gorak, Sumeet Bhatia, Tulin Budak-Alpdogan, James Mason, Maria Teresa Garcia-Romero, Norma Lopez-Santiago, Gabriela Cesarman-Maus, Pankit Vachhani, Sangmin Lee, Vijaya Raj Bhatt, William Blum, Roland B. Walter, Dale Bixby, Ivana Gojo, Madeleine Duvic, Raajit K. Rampal, Marcos de Lima, James Foran, Amir T. Fathi, Aric Cameron Hall, Meagan A. Jacoby, Jeffrey Lancet, Gabriel Mannis, Anthony S. Stein, Alice Mims, David Rizzieri, Rebecca Olin, Alexander Perl, Gary Schiller, Paul Shami, Richard M. Stone, Stephen Strickland, Matthew J. Wieduwilt, Naval Daver, Farhad Ravandi, Sumithira Vasu, Monica Guzman, Gail J. Roboz, Joseph Khoury, Muzaffar Qazilbash, Phyu P. Aung, Branko Cuglievan, Yazan Madanat, Mohamed A. Kharfan-Dabaja, Anna Pawlowska, Justin Taylor, Martin Tallman, Prajwal Dhakal, Andrew A. Lane
Journal: Blood
Blood (2023) 141 (6): 567–578.
https://doi.org/10.1182/blood.2022017865
Published: 2023
Journal Articles

Older Adults with Acute Myeloid Leukemia (AML) Treated in a Pragmatic Trial: How Do Patients’ Function and Health-Related Quality of Life Change with Treatment?

Vijaya Raj Bhatt, Christopher Wichman, Zaid S. Al-Kadhimi, Thuy T. Koll, Alfred L Fisher, Ann Berger, James O. Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu
Journal: Blood
Blood (2022) 140 (Supplement 1): 8991–8992.
https://doi.org/10.1182/blood-2022-156310
Published: 2022
Journal Articles

Ruxolitinib for Treatment of Steroid Refractory Sclerotic Chronic Graft-Versus-Host Disease (cGVHD): Results of a Multicenter Phase II Trial

Vijaya Raj Bhatt, Valerie K Shostrom, Ayman Saad, Betty K. Hamilton, Krishna Gundabolu, Lori Maness, Virender Kumar, Ram I Mahato, Lynette M. Smith, Taiga Nishihori, Stephanie J. Lee
Journal: Blood
Blood (2022) 140 (Supplement 1): 1379–1380.
https://doi.org/10.1182/blood-2022-156340
Published: 2022
Journal Articles

Novel First-in-Class Drug ONC201 As a Post-Transplant Maintenance for AML and MDS: A Phase I Trial in Progress

Vijaya Raj Bhatt, Christopher Wichman, Alyssa C. Bouska, Lori Maness, Zaid S. Al-Kadhimi, Javeed Iqbal, James E. Talmadge, Krishna Gundabolu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12918–12919.
https://doi.org/10.1182/blood-2022-156316
Published: 2022
Journal Articles

Understanding the Treatment Preferences of Adults with Cancer

Prajwal Dhakal, Christopher Wichman, Bunny Pozehl, Meaghann S. Weaver, Alfred L. Fisher, Julie M. Vose, Gregory R. Bociek, Vijaya Raj Bhatt
Journal: Blood
Blood (2022) 140 (Supplement 1): 5070–5072.
https://doi.org/10.1182/blood-2022-164863
Published: 2022
Journal Articles

Prognostic Impact of a Modified European LeukemiaNet (ELN) Genetic Risk Stratification in Predicting Outcomes for Adults with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). a Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis for the CIBMTR Acute Leukemia Writing Committee

Antonio M. Jimenez, MDMSc, Trent Wang, DO,MPH, Marcos de Lima, MD, Krishna V Komanduri, MD, Partow Kebriaei, MD, Mark Litzow, MD, Vijaya Raj Bhatt, MBBS, Frédéric Baron, MD PhD, Ayman Saad, MD MSc, Nandita Khera, MD, Joseph Maakaron, MD, Hemant S. Murthy, MD, Edward A Copelan, Zachariah Defilipp, MD, Christopher Bredeson, MDFRCPC,MSc, Rodrigo Martino, MD, Maxwell Krem, Taiga Nishihori, MD, Mei-Jie Zhang, PhD, Daniel J. Weisdorf, MD, Karen Chen, MS, Wael Saber, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–29.
https://doi.org/10.1182/blood-2020-137589
Published: 2020
Journal Articles

Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population–based trend analysis from 1973 to 2011

Smith Giri, Ranjan Pathak, Mike G. Martin, Vijaya Raj Bhatt
Journal: Blood
Blood (2015) 126 (15): 1861–1863.
https://doi.org/10.1182/blood-2015-05-647412
Published: 2015
Journal Articles

Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study

Smith Giri, Ranjan Pathak, Madan Raj Aryal, Paras Karmacharya, Vijaya Raj Bhatt, Mike G. Martin
Journal: Blood
Blood (2015) 125 (21): 3359–3360.
https://doi.org/10.1182/blood-2015-01-625764
Published: 2015